Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep1020 | Thyroid | ECE2022

Male was not a prognostic risk factor in postoperative DTC patients treated with 131I treatment: a propensity score-matching study

Zheng Wei , Zhou Yaqian , Wang Shen , Wang Xuan , Tan Jian

Objective: Propensity score matching (PSM) was used to study whether male patients with differentiated thyroid cancer (DTC) were the risk factors for prognosis after 131I treatment.Methods: 1677 patients with DTC who underwent total thyroidectomy and received 131I treatment were divided into male group (n= 546) and female group (n= 1131). The PSM method was adopted to process all the data to reduce the influence of...

ea0090p478 | Thyroid | ECE2023

Mouse model of Graves’ ophthalmopathy induced by the immunization with TSHR A and IGF-1Rα subunit gene

Zheng Wei , Wu Ruixin , Li Ning , Wang Xuan , Wang Shen , Tan Jian

Background: The study aimed to establish a mouse model of Graves’ disease (GD) with Graves’ ophthalmopathy (GO; GD+GO) that can represent the clinical disease characteristics.Methods: A eukaryotic expression plasmid of insulin-like growth factor 1 receptor (IGF-1R) α subunit (pcDNA3.1/IGF-1Rα) and a thyrotropin receptor (TSHR) A subunit plasmid (pcDNA3.1/TSHR-289) were injected in female BALB/c mice to induce a GD+GO model. Grouping w...

ea0073oc10.4 | Oral Communications 10: Thyroid | ECE2021

Targeting TSHR and ICAM-1 for treatment of Graves’ disease in BALB/c mice

Zheng Wei , Wang Xuan , Li Wang , Wang Shen , Tan Jian , Jia Qiang , Meng Zhaowei , Rui Zhongying

ObjectiveIn BALB/c mice with GD model, the TSHR and ICAM-1 were targeted for treatment, and new approaches to GD targeted therapy were explored.MethodsThe siRNA targeting TSHR and the ICAM-1 mAb specifically binding ICAM-1 were designed and synthesized. Thirty GD model mice were randomly divided into siRNA treatment group, ICAM-1 mAb treatment group, and untreated GD group, with 10 mice in each group, and 10 ...